Pre-diagnostic plasma proteomics as peripheral immune monitoring for early-onset cancer risk: a prospective UK Biobank analysis of 149 oncology-related proteins
The incidence of early-onset cancer, commonly defined as cancer diagnosed before age 50, is rising in many populations. Scalable tools for capturing pre-diagnostic immune dysregulation in this age window remain limited. Targeted plasma proteomics may provide a practical platform for peripheral immune monitoring, but its value for early-onset cancer risk stratification is unknown.
Authors
- Zhilong Huang (ORCID: https://orcid.org/0009-0008-3474-3423)
Publication Details
- Journal
- Figshare
- Published
- 2026-11-20
- DOI
- https://doi.org/10.6084/m9.figshare.35073826
- Primary Topic
- Advanced Proteomics Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00